Literature DB >> 10029041

Magnetic resonance imaging findings in cerebral fat embolism: correlation with clinical manifestations.

M Takahashi1, R Suzuki, Y Osakabe, J I Asai, T Miyo, G Nagashima, T Fujimoto, Y Takahashi.   

Abstract

OBJECTIVES: Cerebral fat embolism (CFE) is a serious complication after fracture of long bones. The mortality rate of CFE may be high. However, recent progress in treatment may decrease the mortality. We studied the validity of magnetic resonance imaging (MRI) to detect and grade severity of CFE in 11 patients with CFE.
METHODS: Glasgow Coma Scale score, PaO2, PaCO2 at the onset, and minimal hemoglobin and platelet levels were monitored, and phagocytes in bronchoalveolar lavage fluid were counted. Brain computed tomographic and MRI scans were performed serially. MRI findings were graded into four categories according to the severity of T2-weighted images.
RESULTS: High-intensity T2 signals were identified in the various brain regions as early as 4 hours after onset of CFE. The maximum MRI grade significantly correlated with Glasgow Coma Scale score at the onset of CFE (p < 0.01). High-intensity T2 signal lesions fused and enlarged with time. In most cases, they diminished within 2 weeks. Three patients had persistent morbidity.
CONCLUSION: MRI-T2-weighted imaging seems to be the most sensitive imaging technique for diagnosing CFE, and correlates well with the clinical severity of brain Injury. With the aid of proper treatment for pulmonary fat embolism, CFE is a potentially reversible disease that can have a good outcome.

Entities:  

Mesh:

Year:  1999        PMID: 10029041     DOI: 10.1097/00005373-199902000-00021

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  25 in total

1.  Contrast-enhanced MR imaging of cerebral fat embolism: case report and review of the literature.

Authors:  Andrew D Simon; John L Ulmer; James M Strottmann
Journal:  AJNR Am J Neuroradiol       Date:  2003-01       Impact factor: 3.825

Review 2.  Imaging Evaluation of Acute Traumatic Brain Injury.

Authors:  Christopher A Mutch; Jason F Talbott; Alisa Gean
Journal:  Neurosurg Clin N Am       Date:  2016-08-10       Impact factor: 2.509

Review 3.  Dynamic MR imaging patterns of cerebral fat embolism: a systematic review with illustrative cases.

Authors:  K-H Kuo; Y-J Pan; Y-J Lai; W-K Cheung; F-C Chang; J Jarosz
Journal:  AJNR Am J Neuroradiol       Date:  2013-05-02       Impact factor: 3.825

Review 4.  Cerebral Fat Embolism: Recognition, Complications, and Prognosis.

Authors:  Daniel Agustín Godoy; Mario Di Napoli; Alejandro A Rabinstein
Journal:  Neurocrit Care       Date:  2018-12       Impact factor: 3.210

5.  Motor aphasia as a rare presentation of fat embolism syndrome; a case report.

Authors:  Seyed Houssein Saeed-Banadaky; Sima Valizadeh; Marzieh Ghilian
Journal:  Arch Bone Jt Surg       Date:  2015-01-15

6.  The study of cerebral hemodynamics in the hyperacute stage of fat embolism induced by triolein emulsion.

Authors:  Y W Kim; H J Kim; B M Cho; T Y Moon; C K Eun
Journal:  AJNR Am J Neuroradiol       Date:  2006-02       Impact factor: 3.825

7.  Fat embolism syndrome: clinical and imaging considerations: case report and review of literature.

Authors:  Nissar Shaikh; Ashok Parchani; Venkatraman Bhat; Marie Anne Kattren
Journal:  Indian J Crit Care Med       Date:  2008-01

8.  MR imaging and differentiation of cerebral fat embolism syndrome from diffuse axonal injury: application of diffusion tensor imaging.

Authors:  Uttam K Bodanapally; Kathirkamanathan Shanmuganathan; Nitima Saksobhavivat; Clint W Sliker; Lisa A Miller; Andrew Y Choi; Stuart E Mirvis; Jiachen Zhuo; Melvin Alexander
Journal:  Neuroradiology       Date:  2013-03-21       Impact factor: 2.804

9.  MR imaging of the brain in fat embolism syndrome.

Authors:  Joseph Jen-Sho Chen; James C Ha; Stuart E Mirvis
Journal:  Emerg Radiol       Date:  2007-10-13

10.  Cerebral fat embolism and the "starfield" pattern: a case report.

Authors:  Amit Aravapalli; James Fox; Christos Lazaridis
Journal:  Cases J       Date:  2009-11-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.